发现了针对复杂的多延伸膜蛋白的治疗抗体
Amberley D Stephens1, Trevor Wilkinson2
1Department of Biologics Engineering, Oncology R&D, The Discovery Centre, AstraZeneca, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK.
概括
开发针对复杂膜蛋白的有效抗体用于药物发现是具有挑战性的,但正在取得进展. 新的策略和计算工具正在改善针对这些关键细胞表面蛋白的功能抗体的隔离.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药物发现 药物发现 药物发现
背景情况:
- 复杂的整体膜蛋白是药物发现的关键目标.
- 单克隆抗体为调节蛋白质功能或杀死细胞提供特定的结合.
- 抗原制备中的技术挑战阻碍了对膜蛋白的抗体发现.
研究的目的:
- 审查复杂膜蛋白抗原的抗体发现策略的进展.
- 讨论这个领域的新兴主题和未来方向.
- 突出计算技术对抗体发展的潜在影响.
主要方法:
- 审查当前文献和新兴趋势在抗体发现.
- 分析膜蛋白抗原制备中的技术挑战.
- 讨论计算方法,人工智能和机器学习的作用.
主要成果:
- 在为抗体生成准备合适的膜蛋白抗原方面,仍然存在重大挑战.
- 新的战略正在出现,以克服这些技术障碍.
- 计算工具显示了增强抗体发现管道的前景.
结论:
- 抗体工程和抗原制备方面的进步对于向膜蛋白至关重要.
- 计算技术,人工智能和机器学习的整合可能会塑造抗体药物发现的未来.
- 克服目前的局限性将释放针对复杂的膜蛋白的治疗潜力.
更多相关视频
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
8.9K
00:09Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
Published on: August 22, 2019
10.6K
相关概念视频
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
